![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 27358 |
FusionGeneSummary for PKD2_SASH1 |
![]() |
Fusion gene information | Fusion gene name: PKD2_SASH1 | Fusion gene ID: 27358 | Hgene | Tgene | Gene symbol | PKD2 | SASH1 | Gene ID | 25865 | 23328 |
Gene name | protein kinase D2 | SAM and SH3 domain containing 1 | |
Synonyms | HSPC187|PKD2|nPKC-D2 | SH3D6A|dJ323M4.1 | |
Cytomap | 19q13.32 | 6q24.3-q25.1 | |
Type of gene | protein-coding | protein-coding | |
Description | serine/threonine-protein kinase D2 | SAM and SH3 domain-containing protein 1proline-glutamate repeat-containing protein | |
Modification date | 20180523 | 20180523 | |
UniProtAcc | Q13563 | O94885 | |
Ensembl transtripts involved in fusion gene | ENST00000237596, ENST00000508588, ENST00000511337, ENST00000502363, | ENST00000367469, ENST00000367467, ENST00000470750, | |
Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 7 X 6 X 4=168 |
# samples | 1 | 7 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(7/168*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: PKD2 [Title/Abstract] AND SASH1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PKD2 | GO:0006468 | protein phosphorylation | 22228765 |
Hgene | PKD2 | GO:0018105 | peptidyl-serine phosphorylation | 18440775 |
Hgene | PKD2 | GO:0045944 | positive regulation of transcription by RNA polymerase II | 17077180 |
Hgene | PKD2 | GO:0046777 | protein autophosphorylation | 17077180 |
Hgene | PKD2 | GO:0050852 | T cell receptor signaling pathway | 17077180 |
Tgene | SASH1 | GO:0000209 | protein polyubiquitination | 23776175 |
Tgene | SASH1 | GO:0010595 | positive regulation of endothelial cell migration | 23776175 |
Tgene | SASH1 | GO:1900044 | regulation of protein K63-linked ubiquitination | 23776175 |
Tgene | SASH1 | GO:1902498 | regulation of protein autoubiquitination | 23776175 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | AI343884 | PKD2 | chr4 | 88968682 | - | SASH1 | chr6 | 148870939 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
intron-intron | ENST00000237596 | ENST00000367469 | PKD2 | chr4 | 88968682 | - | SASH1 | chr6 | 148870939 | - |
intron-3UTR | ENST00000237596 | ENST00000367467 | PKD2 | chr4 | 88968682 | - | SASH1 | chr6 | 148870939 | - |
intron-intron | ENST00000237596 | ENST00000470750 | PKD2 | chr4 | 88968682 | - | SASH1 | chr6 | 148870939 | - |
intron-intron | ENST00000508588 | ENST00000367469 | PKD2 | chr4 | 88968682 | - | SASH1 | chr6 | 148870939 | - |
intron-3UTR | ENST00000508588 | ENST00000367467 | PKD2 | chr4 | 88968682 | - | SASH1 | chr6 | 148870939 | - |
intron-intron | ENST00000508588 | ENST00000470750 | PKD2 | chr4 | 88968682 | - | SASH1 | chr6 | 148870939 | - |
intron-intron | ENST00000511337 | ENST00000367469 | PKD2 | chr4 | 88968682 | - | SASH1 | chr6 | 148870939 | - |
intron-3UTR | ENST00000511337 | ENST00000367467 | PKD2 | chr4 | 88968682 | - | SASH1 | chr6 | 148870939 | - |
intron-intron | ENST00000511337 | ENST00000470750 | PKD2 | chr4 | 88968682 | - | SASH1 | chr6 | 148870939 | - |
intron-intron | ENST00000502363 | ENST00000367469 | PKD2 | chr4 | 88968682 | - | SASH1 | chr6 | 148870939 | - |
intron-3UTR | ENST00000502363 | ENST00000367467 | PKD2 | chr4 | 88968682 | - | SASH1 | chr6 | 148870939 | - |
intron-intron | ENST00000502363 | ENST00000470750 | PKD2 | chr4 | 88968682 | - | SASH1 | chr6 | 148870939 | - |
Top |
FusionProtFeatures for PKD2_SASH1 |
![]() |
Hgene | Tgene |
PKD2 | SASH1 |
Functions as a cation channel involved in fluid-flowmechanosensation by the primary cilium in renal epithelium(PubMed:18695040). Functions as outward-rectifying K(+) channel,but is also permeable to Ca(2+), and to a much lesser degree alsoto Na(+) (PubMed:11854751, PubMed:15692563, PubMed:27071085,PubMed:27991905). May contribute to the release of Ca(2+) storesfrom the endoplasmic reticulum (PubMed:11854751, PubMed:20881056).Together with TRPV4, forms mechano- and thermosensitive channelsin cilium (PubMed:18695040). PKD1 and PKD2 may function through acommon signaling pathway that is necessary to maintain the normal,differentiated state of renal tubule cells. Acts as a regulator ofcilium length, together with PKD1. The dynamic control of ciliumlength is essential in the regulation of mechanotransductivesignaling. The cilium length response creates a negative feedbackloop whereby fluid shear-mediated deflection of the primarycilium, which decreases intracellular cAMP, leads to ciliumshortening and thus decreases flow-induced signaling. Alsoinvolved in left-right axis specification via its role in sensingnodal flow; forms a complex with PKD1L1 in cilia to facilitateflow detection in left-right patterning. Detection of asymmetricnodal flow gives rise to a Ca(2+) signal that is required fornormal, asymmetric expression of genes involved in thespecification of body left-right laterality (By similarity).{ECO:0000250|UniProtKB:O35245, ECO:0000269|PubMed:11854751,ECO:0000269|PubMed:15692563, ECO:0000269|PubMed:16551655,ECO:0000269|PubMed:18695040, ECO:0000269|PubMed:20881056,ECO:0000269|PubMed:27991905, ECO:0000305}. | May have a role in a signaling pathway. Could act as atumor suppressor. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PKD2_SASH1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PKD2_SASH1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PKD2_SASH1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for PKD2_SASH1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | PKD2 | C2751306 | Polycystic kidney disease, type 2 | 6 | UNIPROT |
Hgene | PKD2 | C0085413 | Polycystic Kidney, Autosomal Dominant | 4 | CTD_human |
Hgene | PKD2 | C0023893 | Liver Cirrhosis, Experimental | 1 | CTD_human |
Hgene | PKD2 | C0035309 | Retinal Diseases | 1 | CTD_human |
Hgene | PKD2 | C0042373 | Vascular Diseases | 1 | CTD_human |
Hgene | PKD2 | C0524851 | Neurodegenerative Disorders | 1 | CTD_human |